Because PR55α inhibits p16 expression in both the normal HPNE cells expressing wild-type p53 and the CD18/HPAF cancer cells expressing mutant p53, we decided to examine the impacts of PR55α on the IR-induced cell cycle response. The gene discussed is CDKN2A; the disease is cancer.